TY - JOUR
T1 - The progress of prophylactic treatment in retinopathy of prematurity
AU - Zhang, Hong Bing
AU - Wang, Xiao Dong
AU - Xu, Kun
AU - Li, Xiao Gang
N1 - Publisher Copyright:
© 2018, International Journal of Ophthalmology (c/o Editorial Office). All rights reserved.
PY - 2018
Y1 - 2018
N2 - Retinopathy of prematurity (ROP) is a retinal vascular disorder frequently found in premature infants. Different therapeutic strategies have been developed to treat ROP. However, there are still many children with ROP suffering by severe limitations in vision or even blindness. Recently, ROP has been suggested to be caused by abnormal development of the retinal vasculature, but not simply resulted by retinal neovascularization which takes about 4 to 6wk after birth in premature infants. Thus, instead of focusing on how to reduce retinal neovascularization, understanding the pathological changes and mechanisms that occur prior to retinal neovascularization is meaningful, which may lead to identify novel target(s) for the development of novel strategy to promote the healthy growth of retinal blood vessels rather than passively waiting for the appearance of retinal neovascularization and removing it by force. In this review, we discussed recent studies about, 1) the pathogenesis prior to retinal neovascularization in oxygen-induced retinopathy (OIR; a ROP in animal model) and in premature infants with ROP; 2) the preclinical and clinical research on preventive treatment of early OIR and ROP. We will not only highlight the importance of the mechanisms and signalling pathways in regulating early stage of ROP but also will provide guidance for actively exploring novel mechanisms and discovering novel treatments for early phase OIR and ROP prior to retinal neovascularization in the future.
AB - Retinopathy of prematurity (ROP) is a retinal vascular disorder frequently found in premature infants. Different therapeutic strategies have been developed to treat ROP. However, there are still many children with ROP suffering by severe limitations in vision or even blindness. Recently, ROP has been suggested to be caused by abnormal development of the retinal vasculature, but not simply resulted by retinal neovascularization which takes about 4 to 6wk after birth in premature infants. Thus, instead of focusing on how to reduce retinal neovascularization, understanding the pathological changes and mechanisms that occur prior to retinal neovascularization is meaningful, which may lead to identify novel target(s) for the development of novel strategy to promote the healthy growth of retinal blood vessels rather than passively waiting for the appearance of retinal neovascularization and removing it by force. In this review, we discussed recent studies about, 1) the pathogenesis prior to retinal neovascularization in oxygen-induced retinopathy (OIR; a ROP in animal model) and in premature infants with ROP; 2) the preclinical and clinical research on preventive treatment of early OIR and ROP. We will not only highlight the importance of the mechanisms and signalling pathways in regulating early stage of ROP but also will provide guidance for actively exploring novel mechanisms and discovering novel treatments for early phase OIR and ROP prior to retinal neovascularization in the future.
KW - Oxygen-induced retinopathy
KW - Retinal neovascularization
KW - Retinopathy of prematurity
UR - http://www.scopus.com/inward/record.url?scp=85050397526&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85050397526&partnerID=8YFLogxK
U2 - 10.18240/ijo.2018.05.24
DO - 10.18240/ijo.2018.05.24
M3 - Review article
AN - SCOPUS:85050397526
SN - 2222-3959
VL - 11
SP - 858
EP - 873
JO - International Journal of Ophthalmology
JF - International Journal of Ophthalmology
IS - 5
ER -